Efficacy and safety of LixiLan, a fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes not adequately controlled on basal insulin: LixiLan-L trial
DIABETOLOGIA(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
DIABETOLOGIA(2016)